Clinical Trial Update: Testosterone in Female Hypoactive Sexual Desire Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating testosterone for hypoactive sexual desire disorder in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Hypoactive Sexual Desire Disorder | Phase 3 | Status: COMPLETED